Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
about
Erythropoietin and Its Angiogenic Activity.Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer.Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization.Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer.
P2860
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Erythropoietin accelerates tum ...... in DLD-1 and Ht-29 xenografts.
@en
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor
@nl
type
label
Erythropoietin accelerates tum ...... in DLD-1 and Ht-29 xenografts.
@en
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor
@nl
prefLabel
Erythropoietin accelerates tum ...... in DLD-1 and Ht-29 xenografts.
@en
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor
@nl
P2093
P2860
P50
P1476
Erythropoietin accelerates tum ...... in DLD-1 and Ht-29 xenografts
@en
P2093
D Rożkiewicz
T Domaniewski
P2860
P2888
P356
10.1007/S11010-016-2779-X
P577
2016-08-20T00:00:00Z